{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:06:40Z","timestamp":1788930400296,"version":"build-2803163510"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There are 150 million women worldwide using combined or progestogen-only hormonal contraceptive methods who may be at risk of sexually transmitted infections (STIs). Previous systematic reviews that have sought to establish whether there is an aetiological association between hormonal contraceptive methods\/use and STIs have been limited in their methods and have mixed findings. We sought to update these reviews using appropriate control groups. We undertook a systematic review following the PRISMA guidelines and meta-analysis to examine the association between the use of all hormonal contraceptive methods and the acquisition of STIs (Neisseria gonorrhoeae, syphilis\/Treponema pallidum, Chlamydia trachomatis, herpes simplex virus, and Trichomonas vaginalis) and\/or bacterial vaginosis in literature published between 2005 and 2020. We analysed the effect of hormonal contraceptive methods\/use separately on the prevalence, incidence and recurrence of STIs. A total of 37 studies were included in this review that reported 61 associations, in which 27 prevalence, eight incidence and two recurrence studies provided 43, 16, and two associations, respectively. We observed a positive association between hormonal contraceptive methods\/use and the risk of chlamydia and herpes but a negative association for trichomoniasis and vaginosis. A negative but statistically insignificant association was observed between hormonal contraceptive methods\/use and gonorrhoea. Hormonal contraceptive methods\/use influences a woman's risk of STIs\/ bacterial vaginosis, but the risk may differ depending on the type of STI. These findings should be contextualized carefully, particularly when formulating practice guidelines and policy, as the effects of hormonal contraceptive methods\/use on the risk of STIs varied in direction when analysed separately by STI.<\/jats:p>","DOI":"10.1038\/s41598-022-24601-y","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T16:35:49Z","timestamp":1669394149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Hormonal contraceptive use and the risk of sexually transmitted infections: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"12","author":[{"given":"Tasnima","family":"Akter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Festin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,25]]},"reference":[{"key":"24601_CR1","unstructured":"Sexually Transmitted Infections (STIs). https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/sexually-transmitted-infections-(stis)."},{"key":"24601_CR2","doi-asserted-by":"publisher","first-page":"e430","DOI":"10.1016\/S2214-109X(15)00085-6","volume":"3","author":"JM Baeten","year":"2015","unstructured":"Baeten, J. M. & Heffron, R. Contraception and sexually transmitted infections: Risks and benefits, hypotheses and evidence. Lancet Glob. Health 3, e430\u2013e431 (2015).","journal-title":"Lancet Glob. Health"},{"key":"24601_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001778","volume":"12","author":"CS Morrison","year":"2015","unstructured":"Morrison, C. S. et al. Hormonal contraception and the risk of HIV acquisition: An individual participant data meta-analysis. PLoS Med. 12, e1001778 (2015).","journal-title":"PLoS Med."},{"key":"24601_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1473-3099(14)71052-7","volume":"15","author":"LJ Ralph","year":"2015","unstructured":"Ralph, L. J., McCoy, S. I., Shiu, K. & Padian, N. S. Hormonal contraceptive use and women\u2019s risk of HIV acquisition: A meta-analysis of observational studies. Lancet. Infect. Dis 15, 181\u2013189 (2015).","journal-title":"Lancet. Infect. Dis"},{"key":"24601_CR5","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1097\/OLQ.0000000000000975","volume":"46","author":"KJ McCarthy","year":"2019","unstructured":"McCarthy, K. J., Gollub, E. L., Ralph, L., van de Wijgert, J. & Jones, H. E. Hormonal contraceptives and the acquisition of sexually transmitted infections: An updated systematic review. Sex. Transm. Dis. 46, 290\u2013296 (2019).","journal-title":"Sex. Transm. Dis."},{"key":"24601_CR6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.contraception.2005.08.012","volume":"73","author":"AP Mohllajee","year":"2006","unstructured":"Mohllajee, A. P., Curtis, K. M., Martins, S. L. & Peterson, H. B. Hormonal contraceptive use and risk of sexually transmitted infections: A systematic review. Contraception 73, 154\u2013165 (2006).","journal-title":"Contraception"},{"key":"24601_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bpobgyn.2008.11.004","volume":"23","author":"CS Morrison","year":"2009","unstructured":"Morrison, C. S., Turner, A. N. & Jones, L. B. Highly effective contraception and acquisition of HIV and other sexually transmitted infections. Best Pract. Res. Clin. Obstet. Gynaecol. 23, 263\u2013284 (2009).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"24601_CR8","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1097\/QAD.0b013e32836290b6","volume":"27","author":"JH Van de Wijgert","year":"2013","unstructured":"Van de Wijgert, J. H., Verwijs, M. C., Turner, A. N. & Morrison, C. S. Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission. AIDS 27, 2141\u20132153 (2013).","journal-title":"AIDS"},{"key":"24601_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073055","volume":"8","author":"LA Vodstrcil","year":"2013","unstructured":"Vodstrcil, L. A. et al. Hormonal contraception is associated with a reduced risk of bacterial vaginosis: A systematic review and meta-analysis. PLoS ONE 8, e73055 (2013).","journal-title":"PLoS ONE"},{"key":"24601_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/OAJC.S135439","volume":"9","author":"J Deese","year":"2018","unstructured":"Deese, J., Pradhan, S., Goetz, H. & Morrison, C. Contraceptive use and the risk of sexually transmitted infection: Systematic review and current perspectives. Open Access J. Contracept. 9, 91 (2018).","journal-title":"Open Access J. Contracept."},{"key":"24601_CR11","volume-title":"Report on Global Sexually Transmitted Infection Surveillance, 2018","author":"WHO","year":"2018","unstructured":"WHO. Report on Global Sexually Transmitted Infection Surveillance, 2018 (World Health Organization, 2018)."},{"key":"24601_CR12","unstructured":"Sustainable Development Goals. https:\/\/www.un.org\/sustainabledevelopment\/health\/."},{"key":"24601_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher, D., Liberati, A., Tetzlaff, J. & Altman, D. G. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann. Intern. Med. 151, 264\u2013269 (2009).","journal-title":"Ann. Intern. Med."},{"key":"24601_CR14","volume-title":"Systematic Reviews CRD\u2019s Guidance for Undertaking Reviews in Health Care","author":"CRD","year":"2009","unstructured":"CRD. Systematic Reviews CRD\u2019s Guidance for Undertaking Reviews in Health Care (Centre for Reviews and Dissemination, 2009)."},{"key":"24601_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/bmjsrh-2019-200509","volume":"46","author":"KM Curtis","year":"2020","unstructured":"Curtis, K. M. et al. Hormonal contraception and HIV acquisition among women: An updated systematic review. BMJ Sex. Reprod. Health 46, 8 (2020).","journal-title":"BMJ Sex. Reprod. Health"},{"key":"24601_CR16","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1177\/1010539516656435","volume":"28","author":"T Akter","year":"2016","unstructured":"Akter, T., Sibbritt, D. & Dawson, A. Workforce interventions to deliver postnatal care to improve neonatal outcomes in low-and lower-middle-income countries: A narrative synthesis. Asia Pac. J. Public Health 28, 659\u2013681 (2016).","journal-title":"Asia Pac. J. Public Health"},{"key":"24601_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/heapol\/czt026","volume":"29","author":"AJ Dawson","year":"2013","unstructured":"Dawson, A. J., Buchan, J., Duffield, C., Homer, C. S. & Wijewardena, K. Task shifting and sharing in maternal and reproductive health in low-income countries: A narrative synthesis of current evidence. Health Policy Plan. 29, 396\u2013408 (2013).","journal-title":"Health Policy Plan."},{"key":"24601_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1742-7622-5-23","volume":"5","author":"WC Wong","year":"2008","unstructured":"Wong, W. C., Cheung, C. S. & Hart, G. J. Development of a quality assessment tool for systematic reviews of observational studies (QATSO) of HIV prevalence in men having sex with men and associated risk behaviours. Emerg. Themes Epidemiol. 5, 23 (2008).","journal-title":"Emerg. Themes Epidemiol."},{"key":"24601_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E Von Elm","year":"2007","unstructured":"Von Elm, E. et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. PLoS Med. 4, e296 (2007).","journal-title":"PLoS Med."},{"key":"24601_CR20","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup, D. F. et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. JAMA 283, 2008\u20132012 (2000).","journal-title":"JAMA"},{"key":"24601_CR21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.contraception.2007.02.002","volume":"75","author":"I Kleinschmidt","year":"2007","unstructured":"Kleinschmidt, I. et al. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception 75, 461\u2013467 (2007).","journal-title":"Contraception"},{"key":"24601_CR22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.contraception.2009.06.007","volume":"80","author":"A Pettifor","year":"2009","unstructured":"Pettifor, A. et al. Use of injectable progestin contraception and risk of STI among South African women. Contraception 80, 555\u2013560 (2009).","journal-title":"Contraception"},{"key":"24601_CR23","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/OLQ.0b013e3181d40ff1","volume":"37","author":"PR Gursahaney","year":"2010","unstructured":"Gursahaney, P. R., Meyn, L. A., Hillier, S. L., Sweet, R. L. & Wiesenfeld, H. C. Combined hormonal contraception may be protective against neisseria gonorrhoeae infection. Sex. Transm. Dis. 37, 356\u2013360 (2010).","journal-title":"Sex. Transm. Dis."},{"key":"24601_CR24","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/OLQ.0b013e3181e8087e","volume":"37","author":"EB Hancock","year":"2010","unstructured":"Hancock, E. B. et al. Comprehensive assessment of sociodemographic and behavioral risk factors for mycoplasma genitalium infection in women. Sex. Transm. Dis. 37, 777\u2013783 (2010).","journal-title":"Sex. Transm. Dis."},{"key":"24601_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/QAD.0b013e32834f990f","volume":"26","author":"H Wand","year":"2012","unstructured":"Wand, H. & Ramjee, G. The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections. AIDS 26, 375\u2013380 (2012).","journal-title":"AIDS"},{"key":"24601_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/OLQ.0000000000000245","volume":"42","author":"H Borgdorff","year":"2015","unstructured":"Borgdorff, H. et al. The impact of hormonal contraception and pregnancy on sexually transmitted infections and on cervicovaginal microbiota in african sex workers. Sex. Transm. Dis. 42, 143\u2013152 (2015).","journal-title":"Sex. Transm. Dis."},{"key":"24601_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1469-0691.2009.02842.x","volume":"15","author":"C Tibaldi","year":"2009","unstructured":"Tibaldi, C. et al. Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: Risk factors and rates of occurrence. Clin. Microbiol. Infect. 15, 670\u2013679 (2009).","journal-title":"Clin. Microbiol. Infect."},{"key":"24601_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/OLQ.0b013e318272fe45","volume":"40","author":"L Masese","year":"2013","unstructured":"Masese, L. et al. Incidence and correlates of Chlamydia trachomatis infection in a high-risk cohort of Kenyan women. Sex. Transm. Dis. 40, 221\u2013225 (2013).","journal-title":"Sex. Transm. Dis."},{"issue":"1","key":"24601_CR29","doi-asserted-by":"publisher","first-page":"e85263","DOI":"10.1371\/journal.pone.0085263","volume":"9","author":"DSM Forcey","year":"2014","unstructured":"Forcey, D. S. M. et al. Chlamydia detection during the menstrual cycle: A cross-sectional study of women attending a sexual health service. PLoS ONE 9(1), e85263 (2014).","journal-title":"PLoS ONE"},{"key":"24601_CR30","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1097\/OLQ.0b013e318199723f","volume":"36","author":"MR Torok","year":"2009","unstructured":"Torok, M. R. et al. The association between oral contraceptives, depot-medroxyprogesterone acetate, and trichomoniasis. Sex. Transm. Dis. 36, 336\u2013340 (2009).","journal-title":"Sex. Transm. Dis."},{"key":"24601_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5146\/tjpath.2013.01161","volume":"29","author":"II Baris","year":"2013","unstructured":"Baris, I. I. & Arman Karakaya, Y. Effects of contraception on cervical cytology: Data from Mardin city. Turk. J. Pathol. 29, 117\u2013121 (2013).","journal-title":"Turk. J. Pathol."},{"key":"24601_CR32","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/infdis\/jit039","volume":"207","author":"JS Huppert","year":"2013","unstructured":"Huppert, J. S., Huang, B., Chen, C., Dawood, H. Y. & Fichorova, R. N. Clinical evidence for the role of trichomonas vaginalis in regulation of secretory leukocyte protease inhibitor in the female genital tract. J. Infect. Dis. 207, 1462\u20131470 (2013).","journal-title":"J. Infect. Dis."},{"key":"24601_CR33","volume":"2014","author":"H Brahmbhatt","year":"2014","unstructured":"Brahmbhatt, H. et al. Trichomonas vaginalis incidence associated with hormonal contraceptive use and HIV infection among women in Rakai, Uganda. J. Sex. Transm. Dis. Print 2014, 916597 (2014).","journal-title":"J. Sex. Transm. Dis. Print"},{"key":"24601_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jri.2015.03.007","volume":"110","author":"S Ngcapu","year":"2015","unstructured":"Ngcapu, S. et al. Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive. J. Reprod. Immunol. 110, 14\u201321 (2015).","journal-title":"J. Reprod. Immunol."},{"key":"24601_CR35","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1097\/AOG.0b013e31828b63a0","volume":"121","author":"AB Berenson","year":"2013","unstructured":"Berenson, A. B., Tan, A., Hirth, J. M. & Wilkinson, G. S. Complications and continuation of intrauterine device use among commercially insured teenagers. Obstet. Gynecol. 121, 951\u2013958 (2013).","journal-title":"Obstet. Gynecol."},{"key":"24601_CR36","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1177\/0956462413482810","volume":"24","author":"C Kenyon","year":"2013","unstructured":"Kenyon, C., Colebunders, R., Buve, A. & Hens, N. Partner-concurrency associated with herpes simplex virus 2 infection in young South Africans. Int. J. STD AIDS 24, 804\u2013812 (2013).","journal-title":"Int. J. STD AIDS"},{"key":"24601_CR37","doi-asserted-by":"publisher","first-page":"e478","DOI":"10.1016\/S2214-109X(15)00086-8","volume":"3","author":"MK Grabowski","year":"2015","unstructured":"Grabowski, M. K. et al. Use of injectable hormonal contraception and women\u2019s risk of herpes simplex virus type 2 acquisition: A prospective study of couples in Rakai, Uganda. Lancet Glob. Health 3, e478\u2013e486 (2015).","journal-title":"Lancet Glob. Health"},{"key":"24601_CR38","unstructured":"Ashraf Ganjoei, T. Risk factors for bacterial vaginosis in women attending a hospital in Kerman, Islamic Republic of Iran. (2005)."},{"key":"24601_CR39","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1086\/503780","volume":"193","author":"CS Bradshaw","year":"2006","unstructured":"Bradshaw, C. S. et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J. Infect. Dis. 193, 1478\u20131486 (2006).","journal-title":"J. Infect. Dis."},{"key":"24601_CR40","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1089\/jwh.2005.14.627","volume":"14","author":"EW Harville","year":"2005","unstructured":"Harville, E. W., Hatch, M. C. & Zhang, J. Perceived life stress and bacterial vaginosis. J. Womens Health 14, 627\u2013633 (2005).","journal-title":"J. Womens Health"},{"key":"24601_CR41","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/01.olq.0000175396.10304.62","volume":"32","author":"JR Schwebke","year":"2005","unstructured":"Schwebke, J. R. & Desmond, R. Risk factors for bacterial vaginosis in women at high risk for sexually transmitted diseases. Sex. Transm. Dis. 32, 654\u2013658 (2005).","journal-title":"Sex. Transm. Dis."},{"key":"24601_CR42","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1258\/095646207782212333","volume":"18","author":"R Amaral","year":"2007","unstructured":"Amaral, R. et al. Evaluation of hygienic douching on the vaginal microflora of female sex workers. Int. J. STD AIDS 18, 770\u2013773 (2007).","journal-title":"Int. J. STD AIDS"},{"key":"24601_CR43","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/sti.2006.022277","volume":"83","author":"AL Evans","year":"2007","unstructured":"Evans, A. L., Scally, A. J., Wellard, S. J. & Wilson, J. D. Prevalence of bacterial vaginosis in lesbians and heterosexual women in a community setting. Sex. Transm. Infect. 83, 470\u2013475 (2007).","journal-title":"Sex. Transm. Infect."},{"key":"24601_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/OLQ.0b013e318156a5d0","volume":"35","author":"TL Cherpes","year":"2008","unstructured":"Cherpes, T. L., Hillier, S. L., Meyn, L. A., Busch, J. L. & Krohn, M. A. A delicate balance: Risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. Sex. Transm. Dis. 35, 78\u201383 (2008).","journal-title":"Sex. Transm. Dis."},{"key":"24601_CR45","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/OLQ.0b013e31816907fa","volume":"35","author":"RS McClelland","year":"2008","unstructured":"McClelland, R. S. et al. A prospective study of risk factors for bacterial vaginosis in HIV-1-seronegative African women. Sex. Transm. Dis. 35, 617 (2008).","journal-title":"Sex. Transm. Dis."},{"key":"24601_CR46","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/OLQ.0b013e31815e4179","volume":"35","author":"JF Peipert","year":"2008","unstructured":"Peipert, J. F. et al. Bacterial vaginosis, race, and sexually transmitted infections: Does race modify the association?. Sex. Transm. Dis. 35, 363\u2013367 (2008).","journal-title":"Sex. Transm. Dis."},{"key":"24601_CR47","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/sti.2008.035543","volume":"85","author":"K Baisley","year":"2009","unstructured":"Baisley, K. et al. Bacterial vaginosis in female facility workers in north-western Tanzania: prevalence and risk factors. Sex. Transm. Infect. 85, 370\u2013375 (2009).","journal-title":"Sex. Transm. Infect."},{"key":"24601_CR48","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.contraception.2009.01.008","volume":"80","author":"SB Rifkin","year":"2009","unstructured":"Rifkin, S. B., Smith, M. R., Brotman, R. M., Gindi, R. M. & Erbelding, E. J. Hormonal contraception and risk of bacterial vaginosis diagnosis in an observational study of women attending STD clinics in Baltimore, MD. Contraception 80, 63\u201367 (2009).","journal-title":"Contraception"},{"key":"24601_CR49","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1365-3156.2009.02235.x","volume":"14","author":"M Yotebieng","year":"2009","unstructured":"Yotebieng, M. et al. Effect of consistent condom use on 6-month prevalence of bacterial vaginosis varies by baseline BV status. Tropical Med. Int. Health 14, 480\u2013486 (2009).","journal-title":"Tropical Med. Int. Health"},{"key":"24601_CR50","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1258\/ijsa.2011.010307","volume":"22","author":"RM Brotman","year":"2011","unstructured":"Brotman, R. M., Melendez, J. H. & Ghanem, K. G. A case control study of anovaginal distance and bacterial vaginosis. Int. J. STD AIDS 22, 231\u2013233 (2011).","journal-title":"Int. J. STD AIDS"},{"key":"24601_CR51","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/OLQ.0b013e318214b82d","volume":"38","author":"E Bukusi","year":"2011","unstructured":"Bukusi, E. et al. Topical penile microbicide use by men to prevent recurrent bacterial vaginosis in sex partners: A randomized clinical trial. Sex. Transm. Dis. 38, 483 (2011).","journal-title":"Sex. Transm. Dis."},{"key":"24601_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.srhc.2010.11.002","volume":"2","author":"NC Kampan","year":"2011","unstructured":"Kampan, N. C. et al. Evaluation of BV\u00ae Blue Test Kit for the diagnosis of bacterial vaginosis. Sex. Reprod. Healthc. 2, 1\u20135 (2011).","journal-title":"Sex. Reprod. Healthc."},{"key":"24601_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/378640","volume":"2012","author":"REM Mascarenhas","year":"2012","unstructured":"Mascarenhas, R. E. M. et al. Prevalence and risk factors for bacterial vaginosis and other vulvovaginitis in a population of sexually active adolescents from Salvador, Bahia, Brazil. Infect. Dis. Obstet. Gynecol. 2012, 1\u20136 (2012).","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"24601_CR54","doi-asserted-by":"publisher","first-page":"e109670","DOI":"10.1371\/journal.pone.0109670","volume":"9","author":"V Jespers","year":"2014","unstructured":"Jespers, V. et al. Prevalence and correlates of bacterial vaginosis in different sub-populations of women in sub-Saharan Africa: A cross-sectional study. PLoS ONE 9, e109670. https:\/\/doi.org\/10.1371\/journal.pone.0109670 (2014).","journal-title":"PLoS ONE"},{"key":"24601_CR55","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/sextrans-2015-052160","volume":"92","author":"SC Francis","year":"2016","unstructured":"Francis, S. C. et al. Bacterial vaginosis among women at high risk for HIV in Uganda: High rate of recurrent diagnosis despite treatment. Sex. Transm. Infect. 92, 142\u2013148 (2016).","journal-title":"Sex. Transm. Infect."},{"key":"24601_CR56","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.contraception.2016.11.006","volume":"95","author":"JP Brooks","year":"2017","unstructured":"Brooks, J. P. et al. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome. Contraception 95, 405\u2013413 (2017).","journal-title":"Contraception"},{"key":"24601_CR57","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41598-022-24601-y","volume":"106","author":"CS Bradshaw","year":"2005","unstructured":"Bradshaw, C. S. et al. Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis. Obstet. Gynecol. 106, 105\u2013114. https:\/\/doi.org\/10.1038\/s41598-022-24601-y (2005).","journal-title":"Obstet. Gynecol."},{"key":"24601_CR58","doi-asserted-by":"publisher","first-page":"622.e621","DOI":"10.1016\/j.ajog.2018.02.017","volume":"218","author":"SL Achilles","year":"2018","unstructured":"Achilles, S. L. et al. Impact of contraceptive initiation on vaginal microbiota. Am. J. Obstet. Gynecol. 218, 622.e621-622.e610 (2018).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"24601_CR59","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/sextrans-2020-054590","volume":"97","author":"J Deese","year":"2021","unstructured":"Deese, J. et al. Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant. Sex. Transm. Infect. 97, 249 (2021).","journal-title":"Sex. Transm. Infect."},{"key":"24601_CR60","first-page":"4","volume":"3","author":"CT Bautista","year":"2016","unstructured":"Bautista, C. T. et al. Bacterial vaginosis: A synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections. Mil. Med. Res. 3, 4 (2016).","journal-title":"Mil. Med. Res."},{"key":"24601_CR61","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/aji.12415","volume":"74","author":"J Deese","year":"2015","unstructured":"Deese, J. et al. Injectable progestin-only contraception is associated with increased levels of pro-inflammatory cytokines in the female genital tract. Am. J. Reprod. Immunol. 74, 357\u2013367 (2015).","journal-title":"Am. J. Reprod. Immunol."},{"key":"24601_CR62","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13405","volume":"86","author":"AT Matubu","year":"2021","unstructured":"Matubu, A. T. et al. Effect of injectable progestin-only contraceptives, depot medroxyprogesterone acetate and norethisterone enanthate, on cytokine production during T-cell activation. Am. J. Reprod. Immunol. 86, e13405 (2021).","journal-title":"Am. J. Reprod. Immunol."},{"key":"24601_CR63","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/0002-9378(87)90122-0","volume":"156","author":"LC Ford","year":"1987","unstructured":"Ford, L. C. et al. Determination of estrogen and androgen receptors in Trichomonas vaginalis and the effects of antihormones. Am. J. Obstet. Gynecol. 156, 1119\u20131121 (1987).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"24601_CR64","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1038\/mi.2016.22","volume":"9","author":"NQ Calla","year":"2016","unstructured":"Calla, N. Q. et al. Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection. Mucosal Immunol. 9, 1571 (2016).","journal-title":"Mucosal Immunol."},{"key":"24601_CR65","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1086\/313818","volume":"30","author":"DA Eschenbach","year":"2000","unstructured":"Eschenbach, D. A. et al. Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin. Infect. Dis. 30, 901\u2013907 (2000).","journal-title":"Clin. Infect. Dis."},{"key":"24601_CR66","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1471-2334-10-120","volume":"10","author":"DE O'Hanlon","year":"2010","unstructured":"O\u2019Hanlon, D. E., Lanier, B. R., Moench, T. R. & Cone, R. A. Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli. BMC Infect. Dis. 10, 120 (2010).","journal-title":"BMC Infect. Dis."},{"key":"24601_CR67","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/1471-2334-11-200","volume":"11","author":"DE O'Hanlon","year":"2011","unstructured":"O\u2019Hanlon, D. E., Moench, T. R. & Cone, R. A. In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect. Dis. 11, 200 (2011).","journal-title":"BMC Infect. Dis."},{"key":"24601_CR68","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1128\/iai.56.4.785-791.1988","volume":"56","author":"W McKenna","year":"1988","unstructured":"McKenna, W., Mickelsen, P., Sparling, P. & Dyer, D. Iron uptake from lactoferrin and transferrin by Neisseria gonorrhoeae. Infect. Immun. 56, 785\u2013791 (1988).","journal-title":"Infect. Immun."},{"key":"24601_CR69","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1046\/j.1365-2958.2000.02058.x","volume":"37","author":"CD Serkin","year":"2000","unstructured":"Serkin, C. D. & Seifert, H. S. Iron availability regulates DNA recombination in Neisseria gonorrhoeae. Mol. Microbiol. 37, 1075\u20131086 (2000).","journal-title":"Mol. Microbiol."},{"key":"24601_CR70","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.contraception.2018.01.011","volume":"97","author":"M Pyra","year":"2018","unstructured":"Pyra, M. et al. Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women. Contraception 97, 357\u2013362 (2018).","journal-title":"Contraception"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24601-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24601-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24601-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T17:29:15Z","timestamp":1669397355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-24601-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,25]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["24601"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-24601-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,25]]},"assertion":[{"value":"1 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20325"}}